PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 110 filers reported holding PULMONX CORP in Q1 2022. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $692,379 | -21.2% | 67,026 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $878,711 | +17.3% | 67,026 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $749,351 | +33.9% | 67,026 | +0.9% | 0.00% | 0.0% |
| Q4 2022 | $559,752 | -73.4% | 66,400 | -47.4% | 0.00% | -80.0% |
| Q3 2022 | $2,104,000 | -27.4% | 126,300 | -35.9% | 0.01% | -16.7% |
| Q2 2022 | $2,899,000 | +4.8% | 196,912 | +76.6% | 0.01% | 0.0% |
| Q1 2022 | $2,766,000 | +5.2% | 111,500 | +36.0% | 0.01% | +20.0% |
| Q4 2021 | $2,630,000 | +65.4% | 82,000 | +85.5% | 0.01% | +66.7% |
| Q3 2021 | $1,590,000 | – | 44,205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 815,019 | $37,279,000 | 40.66% |
| Yu Fan | 303,030 | $13,861,000 | 36.18% |
| ABG Innovation Capital Partners III GP Ltd | 833,333 | $38,117,000 | 18.73% |
| KPCB XIII Associates, LLC | 994,971 | $45,510,000 | 9.36% |
| Iron Triangle Partners LP | 600,000 | $27,444,000 | 3.49% |
| Miura Global Management | 405,000 | $18,525,000 | 3.31% |
| GREAT POINT PARTNERS LLC | 114,345 | $5,230,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 937,032 | $42,860,000 | 0.90% |
| ADAMS STREET PARTNERS LLC | 114,661 | $5,245,000 | 0.84% |
| RTW INVESTMENTS, LP | 1,129,600 | $51,668,000 | 0.81% |